Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity

Author: Ridker, Paul M.

Source: Nutrition Reviews, Volume 65, Supplement 1, December 2007 , pp. 253-259(7)

Publisher: International Life Sciences Institute

Buy & download fulltext article:

Price: $37.00 plus tax (Refund Policy)

Abstract:

Inflammation is recognized as a major etiologic determinant of multiple disease states including myocardial infarction, stroke, diabetes, and metabolic syndrome, and individuals with elevated levels of the inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) are at increased risk of mortality and morbidity from these conditions. Novel screening algorithms, such as the Reynolds Risk Score, that incorporate inflammation can greatly improve risk detection in primary prevention. In high-risk secondary prevention settings such as acute coronary syndrome patients being treated with statin therapy, achieving low levels of plasma hsCRP concentration appears to be of similar importance as achieving low levels of LDL cholesterol. Whether inflammation in general or CRP in particular are appropriate targets for therapy remains controversial and is under investigation. Several novel methods to reduce CRP have been proposed, including direct inhibitors as well as antisense technologies.

Keywords: CARDIOVASCULAR DISEASE RISK; HIGH-SENSITIVITY C-REACTIVE PROTEIN; INFLAMMATORY BIOMARKERS; LDL-C; LIPID LEVELS; STATINS; INFLAMMATION; INFLAMMATORY BIOMARKER; MYOCARDIAL INFARCTION

Document Type: Research article

DOI: http://dx.doi.org/10.1301/nr.2007.dec.S253-S259

Publication date: 2007-12-01

More about this publication?

This journal is now published by Blackwell Publishing. Current issues of this journal are available here. Backfile content is in the process of being reloaded by Blackwell and will shortly be removed from this page and available only from the Blackwell link above.
Information for Authors
Subscribe to this Title
Translation Request
ingentaconnect is not responsible for the content or availability of external websites